siRNA, Anti-C21orf2, 2'-F/2'-OMe/Ribo/Backbone-modified(CAT#: SIRGT01504WQ-2OMe)

The product SIRGT01504WQ-2OMe is a type of small interfering RNA (siRNA) that targets C21orf2 gene and regulates the expression of gene. The siRNA interferes with the expression of C21orf2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001271440.1; NM_001271441.1; NM_001271442.1; NM_004928.2
Alternative Names LRRC76; RDMS; SMDAX; YF5/A2
Related Diseases Retinal Dystrophy, Spondylometaphyseal Dysplasia
Purification HPLC
Target Gene
Gene ID 755
Uniprot ID O43822
Sub Cat Target Species Modification Scale  
SIRGT02504WQ-2F C21orf2 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT01504WQ-RB C21orf2 Human Ribo-modified Inquiry
SIRGT02504WQ-BB C21orf2 Human Backbone-modified Inquiry

Related Products